MEDIPHARM LABS CORPMEDIPHARM LABS CORPMEDIPHARM LABS CORP

MEDIPHARM LABS CORP

No trades
See on Supercharts
Market capitalization
‪32.10 M‬CAD
−0.035CAD
‪−13.08 M‬CAD
‪33.06 M‬CAD
‪384.50 M‬
Beta (1Y)
−0.67

About MEDIPHARM LABS CORP

CEO
David A. Pidduck
Headquarters
Barrie
Employees (FY)
166
Founded
2015
ISIN
CA58504D1006
FIGI
BBG00K17KSD0
MediPharm Labs Corp. is medicinal cannabis company, which engages in the pharmaceutical grade production of cannabis oil products. The company focuses on the downstream secondary extraction methodology, distillation, and cannabinoid isolation and purification. It supplies raw materials, formulations, processing, and packaging for the creation of ready-to-sell derivative products. The company was founded by Patrick McCutcheon in 2015 and is headquartered in Barrie, Canada.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where LABS is featured.

Frequently Asked Questions

The current price of LABS is 0.075 CAD — it has decreased by 6.25% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NEO exchange MEDIPHARM LABS CORP stocks are traded under the ticker LABS.
MEDIPHARM LABS CORP is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
LABS stock is 6.67% volatile and has beta coefficient of −0.67. Check out the list of the most volatile stocks — is MEDIPHARM LABS CORP there?
One year price forecast for MEDIPHARM LABS CORP has a max estimate of 0.100 CAD and a min estimate of 0.100 CAD.
LABS earnings for the last quarter are −0.01 CAD per share, whereas the estimation was −0.01 CAD resulting in a −100.00% surprise. The estimated earnings for the next quarter are −0.01 CAD per share. See more details about MEDIPHARM LABS CORP earnings.
MEDIPHARM LABS CORP revenue for the last quarter amounts to ‪8.51 M‬ CAD despite the estimated figure of ‪10.37 M‬ CAD. In the next quarter revenue is expected to reach ‪8.66 M‬ CAD.
Yes, you can track MEDIPHARM LABS CORP financials in yearly and quarterly reports right on TradingView.
LABS stock has fallen by 11.76% compared to the previous week, the month change is a 15.38% rise, over the last year MEDIPHARM LABS CORP has showed a 16.67% decrease.
LABS net income for the last quarter is ‪−2.97 M‬ CAD, while the quarter before that showed ‪−4.33 M‬ CAD of net income which accounts for 31.48% change. Track more MEDIPHARM LABS CORP financial stats to get the full picture.
Today MEDIPHARM LABS CORP has the market capitalization of ‪30.10 M‬, it has increased by 6.25% over the last week.
No, LABS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, LABS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDIPHARM LABS CORP stock right from TradingView charts — choose your broker and connect to your account.
LABS reached its all-time high on May 14, 2019 with the price of 7.390 CAD, and its all-time low was 0.055 CAD and was reached on Jun 29, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 166.00 employees. See our rating of the largest employees — is MEDIPHARM LABS CORP on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDIPHARM LABS CORP technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDIPHARM LABS CORP stock shows the neutral signal. See more of MEDIPHARM LABS CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on MEDIPHARM LABS CORP future price: according to them, LABS price has a max estimate of 0.10 CAD and a min estimate of 0.10 CAD. Read a more detailed MEDIPHARM LABS CORP forecast: see what analysts think of MEDIPHARM LABS CORP and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDIPHARM LABS CORP EBITDA is ‪−16.36 M‬ CAD, and current EBITDA margin is −49.46%. See more stats in MEDIPHARM LABS CORP financial statements.